Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,463 | 780 | 99.2% |
| Education | $114.79 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,274 | 211 | $0 (2024) |
| Lilly USA, LLC | $2,565 | 183 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,736 | 85 | $0 (2024) |
| ABBVIE INC. | $837.51 | 48 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $538.90 | 28 | $0 (2021) |
| Astellas Pharma US Inc | $499.06 | 25 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $489.00 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $411.27 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $366.97 | 17 | $0 (2019) |
| PFIZER INC. | $292.27 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,112 | 53 | Lilly USA, LLC ($330.80) |
| 2023 | $1,683 | 102 | Lilly USA, LLC ($427.80) |
| 2022 | $888.46 | 52 | Novo Nordisk Inc ($199.51) |
| 2021 | $2,236 | 126 | Novo Nordisk Inc ($427.31) |
| 2020 | $1,813 | 111 | Lilly USA, LLC ($445.45) |
| 2019 | $2,110 | 143 | Novo Nordisk Inc ($457.13) |
| 2018 | $1,942 | 104 | Novo Nordisk Inc ($856.75) |
| 2017 | $1,795 | 93 | Novo Nordisk Inc ($819.08) |
All Payment Transactions
784 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $62.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Gastroenterology | ||||||
| 05/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,168 | 1,488 | $265,311 | $136,803 |
| 2022 | 18 | 1,694 | 2,176 | $383,779 | $219,684 |
| 2021 | 24 | 2,234 | 3,684 | $591,188 | $349,410 |
| 2020 | 21 | 1,649 | 3,712 | $630,327 | $325,763 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 369 | 637 | $126,126 | $61,360 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 328 | 328 | $82,000 | $41,946 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 211 | $27,750 | $14,319 | 51.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 25 | $7,000 | $6,091 | 87.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 32 | $7,200 | $5,262 | 73.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 24 | $2,640 | $1,861 | 70.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $2,240 | $1,159 | 51.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 24 | $1,920 | $948.98 | 49.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 21 | 21 | $1,785 | $919.59 | 51.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 20 | 20 | $1,000 | $811.00 | 81.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 22 | 22 | $1,430 | $746.46 | 52.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 22 | 22 | $2,090 | $660.66 | 31.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 22 | 22 | $550.00 | $289.96 | 52.7% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 22 | 22 | $880.00 | $255.20 | 29.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 14 | $700.00 | $172.90 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 888 | $175,824 | $101,629 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 504 | 504 | $126,000 | $66,181 | 52.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 42 | 71 | $16,685 | $9,443 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 118 | $15,340 | $9,109 | 59.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 88 | 88 | $9,680 | $7,252 | 74.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 28 | $7,840 | $6,909 | 88.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,040 | $4,023 | 79.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 193 | 193 | $6,755 | $3,506 | 51.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 19 | $4,275 | $2,942 | 68.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 41 | 59 | $4,720 | $2,425 | 51.4% |
About Jack Matheny
Jack Matheny is a Family Medicine healthcare provider based in Palatka, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629040043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jack Matheny has received a total of $13,578 in payments from pharmaceutical and medical device companies, with $1,112 received in 2024. These payments were reported across 784 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($13,463).
As a Medicare-enrolled provider, Matheny has provided services to 6,745 Medicare beneficiaries, totaling 11,060 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Palatka, FL
- Active Since 02/02/2006
- Last Updated 04/02/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629040043
Products in Payments
- Ozempic (Drug) $1,604
- TRULICITY (Drug) $1,320
- FARXIGA (Drug) $948.19
- MOUNJARO (Drug) $758.32
- VRAYLAR (Drug) $719.69
- Victoza (Drug) $676.26
- Tresiba (Drug) $388.41
- ENTRESTO (Drug) $366.97
- LOKELMA (Drug) $359.37
- LONHALA MAGNAIR (Drug) $309.43
- EMGALITY (Drug) $285.40
- MYRBETRIQ (Drug) $263.02
- TOUJEO (Drug) $241.98
- INVOKANA (Drug) $240.77
- Levemir (Drug) $233.25
- TRELEGY ELLIPTA (Drug) $229.72
- ELIQUIS (Drug) $199.67
- Tymlos (Biological) $177.54
- XARELTO (Drug) $170.50
- BREZTRI (Drug) $166.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Palatka
Moses Muzquiz, M.d, M.D
Family Medicine — Payments: $2,415
Dr. Neil Benson, Md, MD
Family Medicine — Payments: $2,319
Mrs. Irena Pacanowska-Assefa, Md, MD
Family Medicine — Payments: $923.34
Jose Dizon, Md, MD
Family Medicine — Payments: $291.11
Dave Williams, M.d., M.p.h, M.D., M.P.H
Family Medicine — Payments: $241.35
Maria Perez-Garcia, Md, MD
Family Medicine — Payments: $220.54